These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 17699276

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The case against calcium-based phosphate binders.
    Moe SM, Chertow GM.
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):697-703. PubMed ID: 17699275
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of sevelamer. Comparison with calcium carbonate in the treatment of hyperphosphatemia in hemodialysis patients.
    Shaheen FA, Akeel NM, Badawi LS, Souqiyyeh MZ.
    Saudi Med J; 2004 Jun; 25(6):785-91. PubMed ID: 15195212
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 7. [Sevelamer hydrochloride prevents ectopic calcification of blood vessels].
    Fukushima N, Nagano N.
    Clin Calcium; 2004 Jun; 14(6):116-22. PubMed ID: 15577065
    [Abstract] [Full Text] [Related]

  • 8. Phosphate binders: hold the calcium?
    Bushinsky DA.
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):695-6. PubMed ID: 17699274
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of morbidity and mortality data related to cardiovascular calcification from calcium-containing phosphate binder use in patients undergoing hemodialysis.
    Mason MA, Shepler BM.
    Pharmacotherapy; 2010 Jul; 30(7):741-8. PubMed ID: 20575637
    [Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of sevelamer in the treatment of uncontrolled hyperphosphataemia of haemodialysis patients.
    Almirall J, Lopez T, Vallve M, Ruiz A, Llibre J, Betriu A.
    Nephron Clin Pract; 2004 Jul; 97(1):c17-22. PubMed ID: 15153763
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hyperphosphatemia and phosphate binders.
    Schucker JJ, Ward KE.
    Am J Health Syst Pharm; 2005 Nov 15; 62(22):2355-61. PubMed ID: 16278327
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of combined sevelamer and calcium carbonate therapy for hyperphosphatemia in Japanese hemodialysis patients.
    Iwasaki Y, Takami H, Tani M, Yamaguchi Y, Goto H, Goto Y, Goto Y, Shigematsu T.
    Ther Apher Dial; 2005 Aug 15; 9(4):347-51. PubMed ID: 16076380
    [Abstract] [Full Text] [Related]

  • 14. Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: a pilot study.
    Spiegel DM, Farmer B, Smits G, Chonchol M.
    J Ren Nutr; 2007 Nov 15; 17(6):416-22. PubMed ID: 17971314
    [Abstract] [Full Text] [Related]

  • 15. The role of sevelamer in achieving the kidney disease outcomes quality initiative (K/DOQI) guidelines for hyperphosphatemia.
    Pai AB, Smeeding JE, Brook RA.
    Curr Med Res Opin; 2004 Jul 15; 20(7):991-9. PubMed ID: 15265243
    [Abstract] [Full Text] [Related]

  • 16. Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial.
    Garg JP, Chasan-Taber S, Blair A, Plone M, Bommer J, Raggi P, Chertow GM.
    Arthritis Rheum; 2005 Jan 15; 52(1):290-5. PubMed ID: 15641045
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Front line of management of hyperphosphatemia in hemodialysis patients].
    Yumita S.
    Clin Calcium; 2004 May 15; 14(5):771-7. PubMed ID: 15577041
    [Abstract] [Full Text] [Related]

  • 19. The role of magnesium binders in chronic kidney disease.
    Spiegel DM.
    Semin Dial; 2007 May 15; 20(4):333-6. PubMed ID: 17635824
    [Abstract] [Full Text] [Related]

  • 20. Novel dosage forms and regimens for sevelamer-based phosphate binders.
    Duggal A, Hanus M, Zhorov E, Dagher R, Plone MA, Goldberg J, Burke SK.
    J Ren Nutr; 2006 Jul 15; 16(3):248-52. PubMed ID: 16825030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.